CSPHF News and Press, CStone Pharmaceuticals - Ordinary Shares From 10/12/20

CStone Pharmaceuticals (CSPHF) has completed the Share Subscription Agreement through which an affiliate of Pfizer (PFE) subscribed for newly issued CStone shares at ~$200M (~HK$1.55B), bringing into effect the strategic collaboration announced previously. The Hong Kong Stock Exchange has ...

Pfizer (PFE) subsidiaries will make a $200M equity investment in CStone Pharmaceuticals (CSPHF) for the development and commercialization of latter's sugemalimab (CS1001, PD-L1 antibody) in mainland China. Pfizer obtains exclusive commercialization rights to sugemalimab in mainland China...

Genetron (GTH) and its partner CStone Pharmaceuticals (CSPHF) have launched a clinical trial in China for the development of a companion diagnostic test for avapritinib, a kinase inhibitor discovered by CStone’s partner Blueprint Medicines.The test kit will detect the D8...